Zurück zur Übersicht
| European radiology. doi: 10.1007/s00330-016-4612-z. pii: 10.1007/s00330-016-4612-z |
| Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. |
| Sardanelli F1, Aase HS2, Álvarez M3, Azavedo E4, Baarslag HJ5, Balleyguier C6, Baltzer PA7, Beslagic V8, Bick U9, Bogdanovic-Stojanovic D10, Briediene R11, Brkljacic B12, Camps Herrero J13, Colin C14, Cornford E15, Danes J16, de Geer G17, Esen G18, Evans A19, Fuchsjaeger MH20, Gilbert FJ21, Graf O22, Hargaden G23, Helbich TH24, Heywang-Köbrunner SH25, Ivanov V26, Jónsson Á27, Kuhl CK28, Lisencu EC29, Luczynska E30, Mann RM31, Marques JC32, Martincich L33, Mortier M34, Müller-Schimpfle M35, Ormandi K36, Panizza P37, Pediconi F38, Pijnappel RM39, Pinker K40, Rissanen T41, Rotaru N42, Saguatti G43, Sella T44, Slobodníková J45, Talk M46, Taourel P47, Trimboli RM48, Vejborg I49, Vourtsis A50, Forrai G51 |
 Author information
|
|
Abstract EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is <1 % per round and overdiagnosis is only 1-10 % for a 20-year screening. Mortality reduction was also observed for the age groups 40-49 years and 70-74 years, although with "limited evidence". Thus, we firstly recommend biennial screening mammography for average-risk women aged 50-69 years; extension up to 73 or 75 years, biennially, is a second priority, from 40-45 to 49 years, annually, a third priority. Screening with thermography or other optical tools as alternatives to mammography is discouraged. Preference should be given to population screening programmes on a territorial basis, with double reading. Adoption of digital mammography (not film-screen or phosphor-plate computer radiography) is a priority, which also improves sensitivity in dense breasts. Radiologists qualified as screening readers should be involved in programmes. Digital breast tomosynthesis is also set to become "routine mammography" in the screening setting in the next future. Dedicated pathways for high-risk women offering breast MRI according to national or international guidelines and recommendations are encouraged. KEY POINTS: • EUSOBI and 30 national breast radiology bodies support screening mammography. • A first priority is double-reading biennial mammography for women aged 50-69 years. • Extension to 73-75 and from 40-45 to 49 years is also encouraged. • Digital mammography (not film-screen or computer radiography) should be used. • DBT is set to become "routine mammography" in the screening setting in the next future. |
|
KEYWORDS: Breast cancer, Digital breast tomosynthesis (DBT), Digital mammography, Population-based screening, Recall rate |
|
Publikations ID: 27807699 Quelle: öffnen |
Author information
Schnellinfo
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
